Weiss Ratings Reaffirms Hold (C-) Rating for Astrana Health (NASDAQ:ASTH)

Astrana Health (NASDAQ:ASTH)‘s stock had its “hold (c-)” rating reissued by investment analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Separately, Zacks Research downgraded Astrana Health from a “strong-buy” rating to a “strong sell” rating in a report on Monday, September 1st. Five analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $50.50.

Astrana Health Price Performance

Shares of NASDAQ ASTH opened at $30.42 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. The stock has a fifty day moving average price of $28.80 and a 200 day moving average price of $27.86. Astrana Health has a 1-year low of $21.20 and a 1-year high of $63.20. The company has a market cap of $1.71 billion, a PE ratio of 59.65, a P/E/G ratio of 0.76 and a beta of 0.80.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The firm had revenue of $317.00 million during the quarter. Sell-side analysts forecast that Astrana Health will post 1.15 EPS for the current year.

Institutional Investors Weigh In On Astrana Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Covestor Ltd lifted its holdings in Astrana Health by 777.6% in the first quarter. Covestor Ltd now owns 2,001 shares of the company’s stock valued at $62,000 after acquiring an additional 1,773 shares during the period. Tower Research Capital LLC TRC lifted its holdings in Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after acquiring an additional 3,517 shares during the period. State of Wyoming acquired a new stake in Astrana Health in the second quarter valued at $132,000. AlphaQuest LLC lifted its holdings in Astrana Health by 144.2% in the first quarter. AlphaQuest LLC now owns 4,883 shares of the company’s stock valued at $151,000 after acquiring an additional 2,883 shares during the period. Finally, US Bancorp DE lifted its holdings in Astrana Health by 21.3% in the first quarter. US Bancorp DE now owns 5,791 shares of the company’s stock valued at $180,000 after acquiring an additional 1,015 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.